A yeast expression system was developed for recombinant thymosin alpha-1 production, achieving biological activity equivalent to synthetic peptide — enabling cost-effective large-scale manufacturing.
Key findingRecombinant thymosin alpha-1 produced in Pichia pastoris yeast expression system showed biological activity equivalent to chemically synthesized pepti
What the researchers found
Recombinant thymosin alpha-1 produced in Pichia pastoris yeast expression system showed biological activity equivalent to chemically synthesized peptide, establishing a cost-effective, scalable manufacturing platform for clinical-grade thymosin alpha-1.
Why it matters
Relevant for thymosin-alpha-1, peptide-design, bioavailability.
How the study worked
in-vitro study on thymosin-alpha-1, peptide-design.
What this study cannot tell us
See abstract.
How to read the evidence
preliminary evidence.
When this study was published
Published in 2005.
The bigger picture
Advances peptide research with translational implications.
Questions still open
- Further research needed.
- Clinical translation to evaluate.
Common questions
What was studied?
What was found?
Read the original research
Construction and application of a yeast expression system for thymosin alpha1.
Biocell : official journal of the Sociedades Latinoamericanas de Microscopia Electronica ... et. al, 29(3), 253-9
Citation
Chen, Feng; Chen, Xiang-Ming; Chen, Zhi; Jiang, Han-Liang; Pan, Xiao-Ping; Hu, Zhong-Rong; Liu, Rong-Hua; Chen, Xiao-Ming. (2005). Construction and application of a yeast expression system for thymosin alpha1.. Biocell : official journal of the Sociedades Latinoamericanas de Microscopia Electronica ... et. al, 29(3), 253-9.